Drug Development Solutions
-
Curia R&D Pipeline Overview
2/18/2026
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.
-
Multiparticulates For Modified Release Systems
1/12/2026
Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.
-
Integrated First-In-Human And Clinical Pharmacology Programs
3/7/2022
We accelerate your molecule from first-in-human to proof-of-concept, helping you make critical decisions earlier. Whatever clinical pharmacology study you require, you can expect a fully integrated program from study design to data reporting.
-
Reduce Costs, Increase Efficiencies, And Improve Development Pipelines
4/29/2024
Access a comprehensive suite of biologics testing services meeting cGMP standards, covering characterization, biosafety, and quality control release testing.
-
Improving CLD Efficiency With An Innovative Platform
Cell line development (CLD) bottlenecks can stall progress on the path to clinical trials. Examine how a novel CLD platform can accelerate development for efficient protein and vaccine production.
-
Manufacturing GTP And GMP
3/21/2024
Learn how a one-stop solution for your cell therapy needs can help ensure efficiency, cost-effectiveness, and faster patient treatment. Our Draw-to-Thaw® service streamlines the entire process.
-
Payload-Linker
3/11/2026
Learn how high‑potency infrastructure, strong impurity control, and scalable payload‑linker capabilities help teams manage risk, maintain purity, and advance toward clinical‑stage ADC development.
-
European Center Of Excellence For Clinical Biologics
Explore how our proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.
-
Drug Product Development And Manufacturing Services
3/17/2025
Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.
-
Drug Product Manufacturing: Scaling Product From Bench To Market
5/7/2025
Curia offers comprehensive development and manufacturing services to meet needs through the entire lifecycle of your sterile drug product. Leverage our in-depth expertise and capabilities at any scale, from early clinical through large-scale commercial.